Laurel Wealth Advisors (California)’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$316K Buy
+6,517
New +$286K 0.03% 492
2022
Q3
Sell
-5,522
Closed -$276K 668
2022
Q2
$276K Sell
5,522
-183
-3% -$9.71K 0.03% 522
2022
Q1
$293K Buy
5,705
+189
+3% +$9.76K 0.02% 596
2021
Q4
$276K Buy
+5,516
New +$273K 0.02% 643

Other funds holding SNY

Laurel Wealth Advisors (California)'s SNY Position: Q4 2022 in Review

Laurel Wealth Advisors (California) opened a new position in Sanofi (SNY) in Q4 2022: 6,517 shares worth $316K. The stake represents 0.03% of the portfolio and ranks #492 among its holdings. This is a return to the name: Laurel Wealth Advisors (California) previously reported a position in SNY as recently as Q2 2022.

Laurel Wealth Advisors (California) first reported a position in SNY in Q4 2021 and has held it in 4 quarters since. 643 funds tracked by Wall St. Rank hold SNY as of Q4 2022.

  • Laurel Wealth Advisors (California) held 6,517 shares of Sanofi worth $316K as of Q4 2022.
  • Sanofi was a new Laurel Wealth Advisors (California) position in Q4 2022.
  • Sanofi made up 0.03% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #492 holding.
  • Laurel Wealth Advisors (California) first reported a position in Sanofi in Q4 2021 and has held it in 4 quarters since.
  • 643 funds tracked by Wall St. Rank held Sanofi as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.